Complera Lawsuit

In an ongoing lawsuit, a man from Maryland claims he lost over an inch in height and suffers from spinal deterioration from using Complera and other HIV drugs. He is not the only one who has been injured by this drug. Complera has been named alongside four other HIV drugs in national lawsuits. These lawsuits claim that Complera damages the kidneys and bones.

What Is a Complera Lawsuit?

Complera may be harmful to those who use it, and some of those who were hurt have filed lawsuits against the drug’s maker, Gilead Sciences.

Complera is a newer HIV drug made and sold by Gilead Sciences. It combines existing compounds like tenofovir disoproxil (TDF) and rilpivirine into a daily pill to treat HIV.

When Complera was first approved in 2011 by the Food and Drug Administration (FDA), it was touted as an all-encompassing medication for HIV patients new to therapy

However, those who used Complera may have been put at risk for serious health problems. Though the TDF in the drug can stop the spread of HIV, it can also poison the human body.

Those who used Complera may develop: 

  • Acute kidney injury
  • Chronic kidney disease (CKD)
  • Renal impairment
  • Kidney failure (end-stage renal disease)
  • Bone density loss and broken bones
  • Osteoporosis
  • Tooth loss

Recent lawsuits claim that Gilead did not properly warn users about these health risks before the drug was sold. These lawsuits further state that Gilead had a safer alternative to TDF called tenofovir alafenamide fumarate (TAF) since at least 2001.

If you used Complera and developed any of the side effects mentioned above, you may be able to file a lawsuit. Through a lawsuit, you may receive money to pay for your medical expenses, recover lost earnings if you couldn’t work, and compensate you for your suffering.

Filing a Complera Class-Action Lawsuit

As of 2018, Gilead faces several class-action lawsuits regarding Complera and other TDF drugs. In a class-action lawsuit, groups of people affected by the same issue take legal action together.

A lawsuit can be filed as a class-action from the start, or people filing individually can combine their lawsuits into one. A single person can also join a class-action lawsuit if they were harmed by the same product.

To learn more about filing a Complera class-action lawsuit, you should work with an experienced lawyer. Without a lawyer, it can be very hard for you to file a lawsuit or receive compensation.

A lawyer can help you: 

  • Build a case and collect evidence to support your claims
  • Determine if a class-action lawsuit is right for you
  • File your lawsuit
  • Receive compensation

A benefit to class-action lawsuits is that all the plaintiffs (those taking legal action) claim that the defendant (Gilead or other companies) caused their health issues. This may make it harder for the defendant to dismiss the claims as an isolated incident.

That being said, most mass torts and product liability cases are not handled as class-action lawsuits.

Other Complera Lawsuit Types

If your legal team does not believe a class-action lawsuit is in your best interest, they will help you file your case in another way.

Other options to file a Complera lawsuit include: 

Personal Injury Lawsuit

  • Who Can File: The victim who got sick or hurt
  • Benefits: The victim receives compensation to cover medical treatment, lost income, other expenses

Wrongful Death Lawsuit

  • Who Can File: Family members and/or loved ones of someone who died from their injuries/illness
  • Benefits: The family receives compensation for grief, suffering, medical/funeral expenses

Once a lawsuit is chosen, your lawyers will do their best to get you the most compensation possible. They will communicate with the lawyers representing the defendant and try to resolve the case in a fair and timely manner.

Settlements vs Trials

Lawsuits typically come to an end in one of two ways: they are either settled out of court or go to trial.

Here is an in-depth look at both settlements and trials: 

  • Settlement: In a settlement, neither side admits fault. The plaintiff will be awarded an amount of money agreed upon by both legal teams. Most personal injury cases are settled out-of-court, as most lawyers want to avoid going to trial. Settling a case takes a shorter amount of time than having it go through a trial.
  • Trial: If a case goes to trial, both sides must argue their case. A judge and/or jury will then decide the winner. Trials could award plaintiffs with more money than in a settlement. However, if the jury sides with the defendant, the plaintiff will receive nothing. Also, the defendants could appeal if the plaintiff wins the case.

Legal Help for Complera Health Problems

Despite the recent legal controversies, Complera and other TDF-based HIV drugs are still being made and sold as of 2019.

In 2016, Gilead introduced a new drug called Odefsey. This drug is identical to Complera but contains TAF instead of TDF.

If Gilead had its customers’ best interests at heart, it would have never used TDF-based drugs in the first place. Instead, Gilead continued to create and distribute TDF drugs while TAF was readily available.

In the process, the company put anyone who used its TDF drugs at risk of severe kidney and bone problems — while they were already fighting HIV infections.

If you used Complera in the past or still use the drug today and now suffer from serious kidney or bone problems, a lawsuit could help you receive compensation for your medical treatments.

To learn more, get a free case review now.

Author:HIV Drug Justice Editorial Team
HIV Drug Justice Editorial Team

HIV Drug Justice educates people about the risks of HIV drugs, which can cause kidney failure and bone damage. Our site is managed by the HIV Drug Justice Editorial Team, a group of concerned writers, editors, journalists, and illustrators. Our team helps readers understand what medical and legal options are available if they used dangerous HIV drugs and developed serious health problems as a result.

Last modified: September 17, 2019

View 4 References
  1. Food and Drug Administration. (2016, March 1). Approval Package for: APPLICATION NUMBER: 208351Orig1s000. Retrieved from

  2. Gilead Sciences. (2013, December 13). U.S. FDA Approves Gilead’s Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen. Retrieved from

  3. Holley, et al. v. Gilead Sciences Inc. (N.D. Cal. 2018)

  4. Peirot v. Gilead Sciences Inc. (W.D. La. 2018)